CellCentric’s first-in-class p300/CBP inhibitor drug CCS1477; capsule production complete ready...
Production of CCS1477 in capsule form is now complete, ahead of forthcoming first-in-human clinical...
read moreProduction of CCS1477 in capsule form is now complete, ahead of forthcoming first-in-human clinical...
read moreFirst science companies funded from investment accelerator pilot that joins grant funding with venture...
read more